期刊文献+

高脂诱导胰岛素抵抗ApoE基因敲除小鼠糖脂代谢的变化 被引量:6

The changes of glucose-lipid metabolism in ApoE^(-/-) mice with high-fat induced insulin resistance
原文传递
导出
摘要 目的建立高脂诱导ApoE基因敲除(ApoE^(-/-))小鼠胰岛素抵抗(IR)模型,并探讨其糖脂代谢的变化。方法高脂喂养ApoE^(-/-)小鼠16周建立IR模型,采用3-~3H葡萄糖为示踪剂的扩展高胰岛素钳夹技术评价其胰岛素敏感性和糖脂代谢变化。结果普通饲料喂养ApoE^(-/-)小鼠(NF组)血浆FFA、TC、TG、LDL-C、HDL-C和Ins明显高于C57BL/6J小鼠对照(NC)组(P<0.01和P<0.05),而高脂喂养ApoE^(-/-)小鼠(HF组)上述指标又明显高于NF组(P均<0.01),并且FBG也明显高于NF和NC组(P均<0.01)。钳夹稳态时,HF组Ins明显高于NF和NC组(P均<0.01),FFA、TC、TG虽被抑制,但仍明显高于NF和NC组(P均<0.01);HF组葡萄糖输注率明显低于NF和NC组(P均<0.01)。在钳夹结束时,HF组葡萄糖清除率明显低于NF和NC组(P均<0.01),而肝糖输出率则明显高于NF和NC组(P均<0.01),仅被抑制51%。结论_ApoE^(-/-)小鼠存在糖脂代谢紊乱和IR的遗传特征,长期高脂饲养后更为明显。 Objective To establish an insulin resistance (IR) model and investigate the changes of glucose-lipid metabolism in ApoE^-/- mice with IR induced by high-fat diet. Methods An IR model was established by high-fat diet for 16 weeks in ApoE^- /- mice. The insulin sensitivity and glucose-lipid metabolism in awake mice were evaluated by hyperinsulinemic-euglycemic clamp technique combined with 3-3H glucose as a tracer. Results Plasma insulin (Ins), free fatty acids (FFA), TC, TG, LDL-C and HDL-C were significantly elevated in normal-chow fed ApoE^-/- mice (NF group) compared with C57BL/ 6J mice (NC group)(P〈0. 01-0. 05). In high-fat fed ApoE^-/- mice (HF group), Ins, FFA, TC, TG, LDL-C and HDL-C were significantly higher than the NF group (all P〈0.01). Fasting blood glucose (FBG) was also significantly elevated in HF group compared with NF and NC groups (both P〈0. 01). During the steady-state of clamp, plasma insulin was significantly higher in the HF group than NF and NC groups (both P〈0.01). Although FFA, TC and TG were suppressed in all group, they were still higher in HF group than in NF and NC groups (both P〈0.01). During steady state the glucose infusion rate (GIR) in HF group was significantly decreased as compared with NF and NC group (30. 2±3.1 vs 44. 6±3. 0 and 54. 2 ±2.2 mg · kg^-1· min^-1, P〈0.01). In the end of insulin clamp, glucose disappearance rate (GRd) was significantly lower in HF group than in NF and NC groups (38. 2±0. 8 vs 48. 0±0. 9 and 55.7±2.0 mg · kg^-1 · min^-1 , both P〈0. 01), and HGP was significantly higher in the HF group than in NF and NC groups (8.0±5. 5 vs 4. 3 ±2. 3 and 1.2±0. 8mg · kg^-1 · min^-1 , both P〈0. 01). Conclusions There is an abnormality of glucose-lipid metabolism and insulin resistance in ApoE^-/- mice,especially fed by high-fat.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第8期590-593,共4页 Chinese Journal of Diabetes
基金 国家自然科学基金项目(30771037) 国家教委春晖计划资助项目(2003-56) 重庆市教委科研基金(KJ050304)
关键词 APOE基因敲除小鼠 胰岛素抵抗 糖脂代谢 胰岛素钳夹 ApoE ^-/- mice Insulin resistance Glucose-lipid metabolism Insulin clamp
  • 相关文献

参考文献8

  • 1Bloomgarden ZT.Insulin resistance,dyslipidemia,and cardiovascular disease.Diabetes Care,2007,30:2164-2170.
  • 2Bloomgarden ZT.Insulin resistance concepts.Diabetes Care,2007,30:1320-1326.
  • 3Ayala JE,Bracy DP,McGuinness OP,et al.Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse.Diabetes,2006,55:390-397.
  • 4Yang G,Li L,Tang Y,et al.Short-term pioglitazone treatment prevents free fatty acid-induced hepatic insulin resistance in normal rats:possible role of the resistin and adiponectin.Biochem Biophys Res Commun,2006,339:1190-1196.
  • 5杨刚毅,张凌,李伶,唐毅,李清明,方超,孙勤,李钶,舒朝忠,Gunther Boden.吡格列酮对脂质诱导胰岛素抵抗大鼠的影响及其机制研究[J].中华内分泌代谢杂志,2006,22(3):273-276. 被引量:9
  • 6Phillips JW,Barringhaus KG,Sanders JM,et al.Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.Circulation,2003,108:1994-1999.
  • 7Boord JB,Maeda K,Makowski L,et al.Adipocyte fatty acid-binding protein,aP2,Alters late atherosclerotic lesion formation in severe hypercholesterolemia.Thromb Vasc Biol,2002,22:1686-1691.
  • 8Calkin AC,Forbes JM,Smith CM,et al.Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects.Arterioscler Thromb Vasc Biol,2005,25:1903-1909.

二级参考文献12

  • 1Ye JM, Dzamko N, Cleasby ME, et al. Direct demonstration of lipid sequestration as a mechanism by which resiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin.Diabetologia, 2004,47 : 1306-1313.
  • 2Ye JM, Georgia F, Miguel I, et al. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver. Endocrinology, 2002,142:4527-4529.
  • 3Norris AW, Chen L, Fisher SJ, et al. Muscle-specific PPARgamma-deficinet mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest, 2003,112 : 1808 -1813.
  • 4Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab, 2002,13:18 -23.
  • 5Way JM, Gorgun CZ, Tong Q, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem, 2001,276:25651-25653.
  • 6Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cress-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab, 2003,10:4848-4856.
  • 7Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med, 2002,8 :731-737.
  • 8Yu JG, Javorschi S, Hevener AL, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes, 2002,51:2968-2974.
  • 9章建梁,秦永文,郑兴,邱健力,龚莉,毛红娟,贾伟平,郭冀珍.人血清抵抗素水平与体脂含量和血糖及血压的相关性研究[J].中华医学杂志,2002,82(23):1609-1612. 被引量:23
  • 10章建梁,邱健力,秦永文,郑兴,邹大进,张建荣,张乐之.原发性高血压病患者血清抵抗素与血脂及载脂蛋白的相关性[J].中华内分泌代谢杂志,2003,19(3):205-206. 被引量:13

共引文献8

同被引文献45

  • 1杨刚毅,张凌,李伶,唐毅,李清明,方超,孙勤,李钶,舒朝忠,Gunther Boden.吡格列酮对脂质诱导胰岛素抵抗大鼠的影响及其机制研究[J].中华内分泌代谢杂志,2006,22(3):273-276. 被引量:9
  • 2Raun K,von Voss P,Gotfredsen CF,et al.Liraglutide,a long-acting glucagon-like peptide-1 analog,reduces body weight and food intake in obese candy-fed rats,whereas a dipeptidyl peptidase-Ⅳ inhibitor,vildagliptin,does not.Diabetes,2007,56:8-15.
  • 3Sarruf DA,Thaler JP,Morton GJ,et al.Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.Diabetes,2010,59:1817-1824.
  • 4Zhang X,Yeung DC,Karpisek M,et al.Serum FGF-21 levles are increased in obesity and independently associated with the metabolic syndrome in humans.Diabetes,2008,57:1246-1253.
  • 5Yie J,Hecht R,Patel J,et al.FGF21 N-and C-termini play different roles in receptor interaction and activation.FEBS Lett,2009,583:19-.
  • 6Badman MK,Koester A,Flier JS,et al.Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.Endocrinology,2009,150:4931-4940.
  • 7Coskun T,Bina HA,Schneider MA,et al.Fibroblast growth factor 21 corrects obesity in mice.Endocrinology,2008,149:6018-6027.
  • 8Li L,Li L,Yang M,et al.Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus.Eur J Endocrinol,2009,161:391-395.
  • 9NishimuraT,Nakatake Y,Konishi M,et al.Identification of a novel FGF,FGF-21,preferentially expressed in the liver.Bio Bio Acta,2000,1492:203-206.
  • 10Kharitonenkov A,Shiyanova TL,Koester A,et al.FGF-21 as a novel metabolic regulator.J Clin Invest,2005,115:1627-1635.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部